{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T14:43:07Z","timestamp":1696171387774},"reference-count":28,"publisher":"Cambridge University Press (CUP)","issue":"6","license":[{"start":{"date-parts":[[2010,6,29]],"date-time":"2010-06-29T00:00:00Z","timestamp":1277769600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epidemiol. Infect."],"published-print":{"date-parts":[[2011,6]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>Vaccination coverage and seroprevalence of poliovirus antibodies were assessed in Argentinean children (aged 8\u201312 and 19\u201321 months) living in Cordoba City pre-\/post-implementation of a DTwP-IPV-Hib vaccination programme, and compared to those of controls from neighbouring populations receiving a full oral poliovirus vaccine schedule. Vaccination coverage was higher in control areas pre-intervention; this increased post-intervention in Cordoba (&gt;90%) but not in control areas. Poliovirus types 1 and 2 seroprotection rates were &gt;97% in all groups pre-\/post-intervention. Type 3 seroprotection rates were generally lower, but increased post-intervention in Cordoba becoming significantly higher than control rates. Anti-type 1 and 3 antibody titres increased twofold and sevenfold, respectively, post-intervention, whereas anti-type 2 antibody titres decreased ~40% in the 8\u201312 months group. All titres increased in the 19\u201321 months post-intervention group. The introduction of a three-dose primary DTwP-IPV-Hib schedule maintained protection against poliovirus types 1 and 2, and increased protection against type 3, while vaccine coverage in the study area increased.<\/jats:p>","DOI":"10.1017\/s0950268810001512","type":"journal-article","created":{"date-parts":[[2010,6,29]],"date-time":"2010-06-29T10:01:52Z","timestamp":1277805712000},"page":"826-835","source":"Crossref","is-referenced-by-count":1,"title":["Effect on seroprevalence of anti-poliovirus antibodies and on vaccination coverage of the implementation of a DTwP-IPV-Hib vaccination programme in a South American city"],"prefix":"10.1017","volume":"139","author":[{"given":"S. V.","family":"NATES","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"FRIAS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"BELFIORE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. B.","family":"ISA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. C.","family":"MARTINEZ","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"CHUIT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"ARMONI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"LUXEMBURGER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2010,6,29]]},"reference":[{"key":"S0950268810001512_ref003","first-page":"399","article-title":"Certification of poliomyelitis eradication. WHO Western Pacific Region","volume":"75","year":"2000","journal-title":"Weekly Epidemiological Record"},{"key":"S0950268810001512_ref013","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.micro.58.030603.123625"},{"key":"S0950268810001512_ref005","first-page":"366","article-title":"Global detection of wild and vaccine-derived polioviruses, January 2008\u2013June 2009","volume":"84","year":"2009","journal-title":"Weekly Epidemiological Record"},{"key":"S0950268810001512_ref022","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.02.008"},{"key":"S0950268810001512_ref027","first-page":"75","article-title":"Characteristics of poliovirus strains from long-term excretors with primary immunodeficiencies","volume":"105","author":"Minor","year":"2001","journal-title":"Developments in Biologicals (Basel)"},{"key":"S0950268810001512_ref004","first-page":"572","article-title":"Certification of poliomyelitis eradication \u2013 European Region, June 2002","volume":"51","year":"2002","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"S0950268810001512_ref006","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro1769"},{"key":"S0950268810001512_ref023","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60532-7"},{"key":"S0950268810001512_ref014","first-page":"337","article-title":"Global update on vaccine-derived polioviruses, January 2006\u2013August 2007","volume":"82","year":"2007","journal-title":"Weekly Epidemiological Record"},{"key":"S0950268810001512_ref008","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60533-9"},{"key":"S0950268810001512_ref001","volume-title":"Handbook of Resolutions and Decisions of the World Health Assembly and the Executive Board","volume":"III","year":"1993"},{"key":"S0950268810001512_ref002","first-page":"720","article-title":"Certification of poliomyelitis eradication \u2013 the Americas, 1994","volume":"43","year":"1994","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"S0950268810001512_ref017","first-page":"137","article-title":"Inactivated poliovirus vaccine following oral poliovirus cessation","volume":"81","year":"2006","journal-title":"Weekly Epidemiological Record"},{"key":"S0950268810001512_ref026","unstructured":"26. WHO. Standard procedures for determining immunity to poliovirus using the micro-neutralization test. WHO\/EPI\/GEN 93.9. Geneva, Switzerland: World Health Organization, 1993."},{"key":"S0950268810001512_ref016","doi-asserted-by":"publisher","DOI":"10.1086\/338262"},{"key":"S0950268810001512_ref010","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.06.037457"},{"key":"S0950268810001512_ref021","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.05.032"},{"key":"S0950268810001512_ref009","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(06)70603-X"},{"key":"S0950268810001512_ref018","first-page":"453","article-title":"Conclusions and recommendations of the advisory committee on poliomyelitis eradication, Geneva, 11\u201312 October 2006, Part I","volume":"81","year":"2006","journal-title":"Weekly Epidemiological Record"},{"key":"S0950268810001512_ref028","first-page":"16","article-title":"Circulating vaccine-derived polioviruses: current state of knowledge","volume":"82","author":"Kew","year":"2004","journal-title":"Bulletin of the World Health Organization"},{"key":"S0950268810001512_ref025","unstructured":"25. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects (http:\/\/proj1.sinica.edu.tw\/~irb\/DECLARATION%20OF%20HELSINKI%20(2008).pdf). Accessed 7 April 2010."},{"key":"S0950268810001512_ref024","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2007.122192"},{"key":"S0950268810001512_ref007","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60597-8"},{"key":"S0950268810001512_ref011","first-page":"367","article-title":"Recommendations of 2nd National Consultative Meeting of Indian Academy of Pediatrics (IAP) on polio eradication and improvement of routine immunization","volume":"45","author":"Vashishtha","year":"2008","journal-title":"Indian Pediatrics"},{"key":"S0950268810001512_ref019","first-page":"465","article-title":"Conclusions and recommendations of the advisory committee on poliomyelitis eradication, Geneva, 11\u201312 October 2006, Part II","volume":"81","year":"2006","journal-title":"Weekly Epidemiological Record"},{"key":"S0950268810001512_ref020","doi-asserted-by":"publisher","DOI":"10.1126\/science.1130388"},{"key":"S0950268810001512_ref012","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2006.02.007"},{"key":"S0950268810001512_ref015","doi-asserted-by":"publisher","DOI":"10.1126\/science.1068284"}],"container-title":["Epidemiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0950268810001512","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T04:17:46Z","timestamp":1556338666000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0950268810001512\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,29]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0950268810001512"],"URL":"https:\/\/doi.org\/10.1017\/s0950268810001512","relation":{},"ISSN":["0950-2688","1469-4409"],"issn-type":[{"value":"0950-2688","type":"print"},{"value":"1469-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,29]]}}}